Is asthma protective against COVID‐19?
2020; Wiley; Volume: 76; Issue: 3 Linguagem: Inglês
10.1111/all.14426
ISSN1398-9995
AutoresG Carli, Lorenzo Cecchi, Justin Stebbing, Paola Parronchi, Alessandro Farsi,
Tópico(s)COVID-19 and Mental Health
ResumoAllergyVolume 76, Issue 3 p. 866-868 LETTER TO THE EDITOR Is asthma protective against COVID-19? Giulia Carli, Giulia Carli orcid.org/0000-0001-6400-9205 SOS Allergy and Clinical Immunology, USL Toscana Centro, Prato, ItalySearch for more papers by this authorLorenzo Cecchi, Lorenzo Cecchi orcid.org/0000-0002-0658-2449 SOS Allergy and Clinical Immunology, USL Toscana Centro, Prato, ItalySearch for more papers by this authorJustin Stebbing, Justin Stebbing Department of Surgery and Cancer, Imperial College London, London, UKSearch for more papers by this authorPaola Parronchi, Paola Parronchi Department of Experimental and Clinical Medicine, University of Florence, Florence, ItalySearch for more papers by this authorAlessandro Farsi, Corresponding Author Alessandro Farsi [email protected] orcid.org/0000-0001-6036-9094 SOS Allergy and Clinical Immunology, USL Toscana Centro, Prato, Italy Correspondence Alessandro Farsi, SOS Allergy and Clinical Immunology, USL Toscana Centro, Via Cavour 87/89, Prato, Italy. Email: [email protected]Search for more papers by this author Giulia Carli, Giulia Carli orcid.org/0000-0001-6400-9205 SOS Allergy and Clinical Immunology, USL Toscana Centro, Prato, ItalySearch for more papers by this authorLorenzo Cecchi, Lorenzo Cecchi orcid.org/0000-0002-0658-2449 SOS Allergy and Clinical Immunology, USL Toscana Centro, Prato, ItalySearch for more papers by this authorJustin Stebbing, Justin Stebbing Department of Surgery and Cancer, Imperial College London, London, UKSearch for more papers by this authorPaola Parronchi, Paola Parronchi Department of Experimental and Clinical Medicine, University of Florence, Florence, ItalySearch for more papers by this authorAlessandro Farsi, Corresponding Author Alessandro Farsi [email protected] orcid.org/0000-0001-6036-9094 SOS Allergy and Clinical Immunology, USL Toscana Centro, Prato, Italy Correspondence Alessandro Farsi, SOS Allergy and Clinical Immunology, USL Toscana Centro, Via Cavour 87/89, Prato, Italy. Email: [email protected]Search for more papers by this author First published: 01 June 2020 https://doi.org/10.1111/all.14426Citations: 110Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1W-jie G, W-hua L, Zhao Y, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide Analysis. Eur Respir J. 2020; 55(5): 2000547. https://doi.org/10.1183/13993003.00547-2020 10.1183/13993003.00547-2020 PubMedWeb of Science®Google Scholar 2Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020; 75: 1730-1741. https://doi.org/10.1111/all.14238 10.1111/all.14238 CASPubMedWeb of Science®Google Scholar 3Channappanavar R, Fehr AR, Vijay R, et al. Dysregulated Type I interferon and inflammatory monocyte-macrophage responses cause lethal Pneumonia in SARS-CoV-Infected Mice. Cell Host Microbe. 2016; 19(2): 181-193. https://doi.org/10.1016/j.chom.2016.01.007 10.1016/j.chom.2016.01.007 CASPubMedWeb of Science®Google Scholar 4Gonzales-van Horn SR, Farrar JD. Interferon at the crossroads of allergy and viral infections. J Leukoc Biol. 2015; 98(2): 185-194. 10.1189/jlb.3RU0315-099R CASPubMedWeb of Science®Google Scholar 5Lebre MC, van Capel TM, Bos JD, Knol EF, Kapsenberg ML, de Jong EC. Aberrant function of peripheral blood myeloid and plasmacytoid dendritic cells in atopic dermatitis patients. J Allergy Clin Immunol. 2008; 122(5): 969-976. 10.1016/j.jaci.2008.08.028 CASPubMedWeb of Science®Google Scholar 6Maggi E, Parronchi P, Manetti R, et al. Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones. J Immunol. 1992; 148(7): 2142-2147. 10.4049/jimmunol.148.7.2142 CASPubMedWeb of Science®Google Scholar 7Gern . JE. How rhinovirus infections cause exacerbations of asthma. Clin Exp Allergy. 2015; 45: 32-42. 10.1111/cea.12428 CASPubMedWeb of Science®Google Scholar 8Cameron MJ, Ran L, Xu L, et al. Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. J Virol. 2007; 81(16): 8692-8706. 10.1128/JVI.00527-07 CASPubMedWeb of Science®Google Scholar 9Richardson PJ, Corbellino M, Stebbing J. Baricitinib for COVID-19: a suitable treatment? – Authors' reply. Lancet Infect Dis. 2020; 19: 1473-3099. Google Scholar 10Yamaya M, Nishimura H, Deng X, et al. Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells. Resp Investig. 2020; 58(3): 155-168. 10.1016/j.resinv.2019.12.005 PubMedWeb of Science®Google Scholar 11Lam KP, Chu YT, Lee MS, et al. Inhibitory effects of albuterol and fenoterol on RANTES and IP-10 expression in bronchial epithelial cells. Pediatr Allergy Immunol. 2011; 22(4): 431-439. 10.1111/j.1399-3038.2010.01119.x PubMedWeb of Science®Google Scholar Citing Literature Volume76, Issue3March 2021Pages 866-868 This article also appears in:COVID-19 Articles in Allergy ReferencesRelatedInformation
Referência(s)